Although our RA population is characterized by a relatively high rate of seronegative and ACPA-negative patients, perhaps reflecting a more difficult-to-diagnose arthritis population in our tertiary care setting, the ability of mtDNA measurements to distinguish between HC and RA was observed regardless of the serological status of the RA patients. This evidence concerns the gene PRTN3 and rheumatoid arthritis.